Celularity Inc (CELU)
Healthcare
Biotechnology
0.66 $
+3.9%
vs. previous close
Closing price · As of: 3. Aug 2026
Celularity Inc (CELU) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -13 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| 0.0 | -1.1 | -63 | -110 | -138 | -39 | -6.4 | -13 | |
| 4.8 | 6.2 | 8.2 | 8.8 | 9.4 | 9.3 | 7.9 | 7.3 | |
| 4.5 | 3.7 | 4.4 | 40 | 16 | 15 | 12 | 10 | |
| -52 | 140 | 47 | -7.7 | – | – | – | – | |
| -1.3 | 0.1 | 3.6 | -11 | -15 | 3.3 | 22 | 34 | |
| 1.9 | 0.0 | 28 | 6.2 | 5.2 | 4.0 | 0.2 | 0.0 | |
| -31 | -287 | -13 | -5.9 | -5.2 | – | 0.5 | – | |
| – | – | – | – | 39 | – | 0.0 | 5.9 | |
| – | 6.5 | -0.3 | 0.0 | -0.1 | – | – | – | |
| – | -0.2 | – | 0.0 | 86 | -15 | -14 | -0.1 | |
| 0.0 | 289 | 102 | 99 | 120 | 24 | 6.7 | 19 | |
| -31 | 0.9 | 26 | -17 | -23 | -19 | 0.8 | 5.4 | |
| -1.9 | -1.1 | -91 | -116 | -143 | -43 | -6.6 | -13 |
Data as of: August 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.